Galectin-7 on MDA-MB-231 Triple-Negative Breast Cancer cells
Galectin-7 is a key player in cancer biology, particularly in triple-negative breast cancer (TNBC) where it promotes immune evasion and tumor progression. This study shows the transcriptional signature of MDA-MB-231 TNBC cells exposed to galectin-7 for 8 h and 16 h.